Home » Topics » BioWorld Science

BioWorld Science
RSS

Targeting IL-33 release may be an approach for treating HCC

July 13, 2022

Co-targeting MAPK and YAP-TEAD signaling as therapeutic strategy in melanoma

July 13, 2022

Royal College of Surgeons in Ireland discloses HDAC6 inhibitors

July 13, 2022

Chinese researchers synthesize new GTPase KRAS inhibitors

July 13, 2022

Galapagos NV presents new DDR inhibitors

July 13, 2022

Shanghai Visonpharma discloses new GTPase KRAS inhibitors

July 13, 2022

MJFF grant supports evaluation of EpicentRx's NLRP3 inflammasome inhibitor for Parkinson's

July 13, 2022

Beijing Innocare Medical Technology patents JAK inhibitors

July 13, 2022

Renovacor to advance AAV gene therapy program for arrhythmogenic cardiomyopathy

July 13, 2022

VesiVax Af3/9 vaccine protects against invasive pulmonary aspergillosis

July 13, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...